| 发明名称 |
THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD |
| 摘要 |
A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments. |
| 申请公布号 |
US2015182475(A1) |
申请公布日期 |
2015.07.02 |
| 申请号 |
US201514658457 |
申请日期 |
2015.03.16 |
| 申请人 |
U.S. NUTRACEUTICALS, LLC d/b/a Valensa International |
发明人 |
MINATELLI John A.;HILL W. STEPHEN;MOERCK RUDI E. |
| 分类号 |
A61K31/122;A61K31/685 |
主分类号 |
A61K31/122 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A dietary supplement composition comprising a therapeutic amount of astaxanthin derived from a synthetic ester or dial, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. |
| 地址 |
EUSTIS FL US |
